The store will not work correctly when cookies are disabled.
3'-((2-(6-methoxy-2-methylquinolin-4-yl)hydrazono)methyl)phenol
ID: ALA4467366
PubChem CID: 155532551
Max Phase: Preclinical
Molecular Formula: C18H17N3O2
Molecular Weight: 307.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2nc(C)cc(N/N=C/c3cccc(O)c3)c2c1
Standard InChI: InChI=1S/C18H17N3O2/c1-12-8-18(16-10-15(23-2)6-7-17(16)20-12)21-19-11-13-4-3-5-14(22)9-13/h3-11,22H,1-2H3,(H,20,21)/b19-11+
Standard InChI Key: WFGDLFDTVVITRH-YBFXNURJSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
4.2579 -21.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2567 -22.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9648 -22.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9630 -21.0981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6716 -21.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6724 -22.3224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3809 -22.7294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0892 -22.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0844 -21.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3753 -21.0931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7985 -22.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3710 -20.2759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0765 -19.8636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5501 -21.0985 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5499 -20.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7864 -20.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4919 -19.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2003 -20.2658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9053 -19.8541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9014 -19.0361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1866 -18.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4845 -19.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6150 -20.2593 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
10 12 1 0
12 13 1 0
1 14 1 0
14 15 1 0
13 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
19 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.35 | Molecular Weight (Monoisotopic): 307.1321 | AlogP: 3.70 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.19 | CX Basic pKa: 7.42 | CX LogP: 3.50 | CX LogD: 3.31 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.57 | Np Likeness Score: -1.08 |
References
1. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S.. (2019) Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)., 182 [PMID:31514018] [10.1016/j.ejmech.2019.111649] |